Results 1 -
10
of
12
for
Bone marrow neoplasm
- ... and their functional and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, ... Citation on PubMed
- ... bone fractures. Systemic mastocytosis with an associated hematologic neoplasm and mast ... cells, which are produced in bone marrow, abnormally accumulate in one or more tissues. In ...
- ... associated with primary myelofibrosis, a condition in which bone marrow is replaced by scar tissue ... R. Somatic mutations of calreticulin in myeloproliferative neoplasms. N Engl J Med. 2013 Dec 19;369( ...
- ... mutation when it is caused by an underlying bone marrow disorder. It is unknown how one particular ... and clinical relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. ...
- ... gene mutations increase the risk of developing these bone marrow disorders in people with Down ... classification of myeloid neoplasms and acute leukemia: rationale and important changes. Blood. ...
- ... an impairment of bone marrow function known as bone marrow failure.The MPL gene mutations involved in ... relevance in myeloproliferative neoplasms: JAK2, MPL, TET2, ASXL1, CBL, IDH and IKZF1. ...
- ... TET2 gene mutations play in the development of bone marrow disorders. ... 2 (TET2) gene in familial myeloproliferative neoplasms. Blood. 2009 Aug 20;114(8):1628-32. ...
- ... found in certain cancers, including cancer of the bone marrow (multiple myeloma), salivary ... in basal cell salivary neoplasms: linkage to tumor development and progression. Mod Pathol. ...
- ... cell. These stem cells are located in the bone marrow and have the potential to develop into red ... Casadevall N. Molecular aspects of myeloproliferative neoplasms. Int J Hematol. 2010 Mar;91(2):165- ...
- ... cells crowd out blood-forming cells in the bone marrow, leads to a general reduction in the ... Langerhans cell histiocytosis is a neoplasm and consequently its recurrence is a relapse: In ...